Literature DB >> 17185038

Cholesterol: a potential therapeutic target in Leishmania infection?

Thomas J Pucadyil1, Amitabha Chattopadhyay.   

Abstract

Leishmania are obligate intracellular parasites that invade and survive within host macrophages and can result in visceral leishmaniasis, a major public health problem worldwide. The entry of intracellular parasites, in general, involves interaction with the plasma membrane of host cells. Cholesterol in host cell membranes was recently shown to be necessary for binding and internalization of Leishmania and for the efficient presentation of leishmanial antigens in infected macrophages. This article describes the need to explore cyclodextrin-based compounds, which modulate host membrane cholesterol levels, as a possible therapeutic strategy against leishmaniasis in addition to other intracellular parasites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185038     DOI: 10.1016/j.pt.2006.12.003

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  12 in total

1.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

2.  Stereospecific requirement of cholesterol in the function of the serotonin1A receptor.

Authors:  Md Jafurulla; Bhagyashree D Rao; Sugunan Sreedevi; Jean-Marie Ruysschaert; Douglas F Covey; Amitabha Chattopadhyay
Journal:  Biochim Biophys Acta       Date:  2013-09-02

3.  Differential effect of cholesterol and its biosynthetic precursors on membrane dipole potential.

Authors:  Sourav Haldar; Ravi Kumar Kanaparthi; Anunay Samanta; Amitabha Chattopadhyay
Journal:  Biophys J       Date:  2012-04-03       Impact factor: 4.033

4.  Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.

Authors:  A C Brown; E Koufos; N V Balashova; K Boesze-Battaglia; E T Lally
Journal:  Mol Oral Microbiol       Date:  2015-10-12       Impact factor: 3.563

5.  Cholesterol-lowering drug, in combination with chromium chloride, induces early apoptotic signals in intracellular L. donovani amastigotes, leading to death.

Authors:  Amit Kumar Verma; Bhakti Laha; Monika Pandey; Uttariya Pal; Monidipa Ghosh
Journal:  J Biosci       Date:  2017-09       Impact factor: 1.826

Review 6.  Membrane organization and function of the serotonin(1A) receptor.

Authors:  Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

Review 7.  The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction?

Authors:  Yamuna Devi Paila; Amitabha Chattopadhyay
Journal:  Glycoconj J       Date:  2008-12-04       Impact factor: 2.916

8.  Use of a Cholesterol Recognition Amino Acid Consensus Peptide To Inhibit Binding of a Bacterial Toxin to Cholesterol.

Authors:  Evan Koufos; En Hyung Chang; Elnaz S Rasti; Eric Krueger; Angela C Brown
Journal:  Biochemistry       Date:  2016-08-17       Impact factor: 3.162

Review 9.  Emerging therapeutic targets for treatment of leishmaniasis.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Opin Ther Targets       Date:  2018-05-09       Impact factor: 6.902

10.  The landscape of host transcriptional response programs commonly perturbed by bacterial pathogens: towards host-oriented broad-spectrum drug targets.

Authors:  Yared H Kidane; Christopher Lawrence; T M Murali
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.